¹Ù·Î°¡±â ¸Þ´º
¹Ù·Î°¡±â ¸Þ´º
º»¹®³»¿ë ¹Ù·Î°¡±â
¸ÞÀθ޴º ¹Ù·Î°¡±â
"CD163ΔSRCR5 MARC-145 cells resist PRRSV-2 infection via inhibiting virus uncoating, which require the interaction of CD163 with calpain1"À̶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î,
±âÁ¸¿¡ CD163ÀÌ PRRSVÀÇ receptorÀÎ °ÍÀº Àß ¾Ë·ÁÁ® ÀÖÁö¸¸, CD163À» Marc-145cell¿¡¼ CRISPR/Cas9 ±â¼úÀ» ÅëÇØ deletion½ÃÅ´À¸·Î½á CD163À» ÅëÇÑ virusÀÇ uncoatingÀÌ calpain 1(calcium-dependent neutral protease 1)À̶ó´Â enzyme°úÀÇ interactionÀ» ÅëÇØ ÀÌ·ç¾îÁø´Ù´Â »ç½ÇÀ» »õ·Ó°Ô ¹àÈù ³í¹®ÀÔ´Ï´Ù.
Á¦ ¿¬±¸¿¡ ÀÖ¾î Âü°íÇÒ¸¸ÇÑ ³»¿ëÀ̶ó ¼Ò°³½ÃÄѵ帮°íÀÚ ¼±Á¤ÇϰԵǾú½À´Ï´Ù.
¿½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
³í¹® ¸µÅ©: https://www.frontiersin.org/articles/10.3389/fmicb.2019.03115/full